- Home
- SNT vs INCR Comparison
SNT vs INCR Comparison
Compare SNT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- INCR
- Stock Information
- Founded
- SNT 1965
- INCR 1994
- Country
- SNT Canada
- INCR Israel
- Employees
- SNT N/A
- INCR N/A
- Industry
- SNT Telecommunications Equipment
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- SNT Telecommunications
- INCR Health Care
- Exchange
- SNT Nasdaq
- INCR Nasdaq
- Market Cap
- SNT 64.6M
- INCR 65.3M
- IPO Year
- SNT 1993
- INCR N/A
- Fundamental
- Price
- SNT $3.45
- INCR $1.46
- Analyst Decision
- SNT
- INCR
- Analyst Count
- SNT 0
- INCR 0
- Target Price
- SNT N/A
- INCR N/A
- AVG Volume (30 Days)
- SNT 73.4K
- INCR 29.6K
- Earning Date
- SNT 11-12-2024
- INCR 12-24-2024
- Dividend Yield
- SNT N/A
- INCR N/A
- EPS Growth
- SNT N/A
- INCR N/A
- EPS
- SNT 0.06
- INCR N/A
- Revenue
- SNT $34,455,000.00
- INCR $72,420,918.00
- Revenue This Year
- SNT N/A
- INCR N/A
- Revenue Next Year
- SNT N/A
- INCR $39.30
- P/E Ratio
- SNT $54.86
- INCR N/A
- Revenue Growth
- SNT 2.04
- INCR N/A
- 52 Week Low
- SNT $1.08
- INCR $1.17
- 52 Week High
- SNT $3.35
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- SNT 71.93
- INCR 52.10
- Support Level
- SNT $2.90
- INCR $1.30
- Resistance Level
- SNT $3.09
- INCR $1.47
- Average True Range (ATR)
- SNT 0.19
- INCR 0.05
- MACD
- SNT 0.00
- INCR 0.02
- Stochastic Oscillator
- SNT 98.16
- INCR 88.83
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.